Cannabinoids as antioxidants and neuroprotectants

[Guest guest]

The US government owns a patent demonstreating the use of cannabis for

treatment of disease. Because the government owns the patent, they

prevent further research.

 

Alobar

 

Cannabinoids as antioxidants and neuroprotectants

 

Abstract

 

Cannabinoids have been found to have antioxidant properties, unrelated

to NMDA receptor antagonism. This new found property makes

cannabinoids useful in the treatment and prophylaxis of wide variety

of oxidation associated diseases, such as ischemic, age-related,

inflammatory and autoimmune diseases. The cannabinoids are found to

have particular application as neuroprotectants, for example in

limiting neurological damage following ischemic insults, such as

stroke and trauma, or in the treatment of neurodegenerative diseases,

such as Alzheimer's disease, Parkinson's disease and HIV dementia.

Nonpsychoactive cannabinoids, such as cannabidoil, are particularly

advantageous to use because they avoid toxicity that is encountered

with psychoactive cannabinoids at high doses useful in the method of

the present invention. A particular disclosed class of cannabinoids

useful as neuroprotective antioxidants is formula (I) wherein the R

group is independently selected from the group consisting of H,

CH.sub.3, and COCH.sub.3. ##STR1##

 

http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1 & Sect2=HITOFF & d=PALL & p=1 & u=%\

2Fnetahtml%2FPTO%2Fsrchnum.htm & r=1 & f=G & l=50 & s1=6630507.PN. & OS=PN/6630507 & RS=PN/6\

630507